Maravai LifeSciences
- Market cap
- 1.11B
- P/E (TTM)i
- -14.02
- P/Bi
- 5.41
- EPSi
- -0.90
- Div yieldi
- 0.00%
- 52W posi
- 71%
Anonymous reader poll. Unscientific, not investment advice.
Maravai LifeSciences ended the session at 7.43, down 5.35%. Its market capitalisation is about 1.11B, the #3116 most valuable US-listed company we track. Valuation-wise, the P/E sits at -14.81, 455% below the five-year average of 4.18. Across 5 analysts the consensus rating is Buy, with an average price target of 7.83 (+5%). The shares sit 71% of the way up their 52-week range of 2.55 to 9.42.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 4% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Recent price momentum is +75.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 8.3% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 7.85
- Open
- 7.65
- Day range
- 7.22 - 7.73
- Avg price
- 7.44
- Volume
- 4.27M
- Turnover
- 31.79M
- Turnover ratei
- 4.16%
- Volume ratioi
- 1.33
- Amplitudei
- 6.50%
- 52-week rangei
- 2.55 - 9.42
Valuation
- P/Ei
- -8.26
- P/E (TTM)i
- -14.02
- P/Bi
- 5.41
- EPSi
- -0.90
- Book value / shi
- 1.37
- Net profit
- -134.09M
- Net assets
- 204.56M
Share structure
- Market cap
- 1.11B
- Float capi
- 762.35M
- Shares out
- 148.99M
- Float sharesi
- 102.60M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-11-20
21.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-18.19M net over the window
Short interest
- Shares short
- 12.37M
- % of floati
- 8.30%
- Days to coveri
- 4.65
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Maravai LifeSciences (MRVI)?
Maravai LifeSciences last traded at 7.43. The quote on this page refreshes every few seconds while US markets are open.
What is Maravai LifeSciences's market cap?
About 1.11B.
What is the P/E ratio of Maravai LifeSciences?
The trailing twelve-month P/E is -14.02, below its own 5-year average of 4.18 — toward the bottom of its historical range (0.72% percentile). See the Valuation tab for the full history.
Does Maravai LifeSciences pay a dividend?
Maravai LifeSciences does not currently pay a regular dividend.
Is Maravai LifeSciences a buy according to analysts?
The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 7.83, which implies 5.4% upside from the current price. This is not investment advice.
What is Maravai LifeSciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Maravai LifeSciences a B (Buy). Twelve-month momentum in the top 4% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.